The newly approved methastatic Renal Cell Cancer (mRCC) Phase 1/2a trial began in 4Q24, and Genenta expects to treat six ...
GEMMA Biotherapeutics —a new therapeutics company founded by gene therapy pioneer Dr. Jim Wilson—has named May Orfali, MD, ...
Peptone, a biotech company developing novel therapeutics targeting intrinsically disordered proteins (IDPs) to treat diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback